Cargando…

P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD

Detalles Bibliográficos
Autor principal: Liu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430462/
http://dx.doi.org/10.1097/01.HS9.0000972020.41459.e6
_version_ 1785090969903824896
author Liu, Fang
author_facet Liu, Fang
author_sort Liu, Fang
collection PubMed
description
format Online
Article
Text
id pubmed-10430462
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104304622023-08-17 P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD Liu, Fang Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430462/ http://dx.doi.org/10.1097/01.HS9.0000972020.41459.e6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Liu, Fang
P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD
title P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD
title_full P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD
title_fullStr P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD
title_full_unstemmed P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD
title_short P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD
title_sort p1283: anti-cd19 chimeric antigen receptor therapy followed by umbilical cord blood transplantation in pediatric relapsed or refractory acute lymphoblastic leukemia: good survival and less gvhd
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430462/
http://dx.doi.org/10.1097/01.HS9.0000972020.41459.e6
work_keys_str_mv AT liufang p1283anticd19chimericantigenreceptortherapyfollowedbyumbilicalcordbloodtransplantationinpediatricrelapsedorrefractoryacutelymphoblasticleukemiagoodsurvivalandlessgvhd